FDG PET/CT imaging in canine cancer patients

Anders Elias Hansen; Fintan McEvoy; Svend Aage Engelholm; Ian Law; Annemarie Thuri Kristensen

doi:10.1111/j.1740-8261.2010.01757.x

FDG PET/CT imaging in canine cancer patients

Anders Elias Hansen, Fintan McEvoy, Svend Aage Engelholm, Ian Law, Annemarie Thuri Kristensen

45 Citations (Scopus)

Abstract

2-Deoxy-2-[¹⁸F]fluoro-d-glucose positron emission tomography/computed tomography (FDG PET/CT) is becoming increasingly available as an imaging modality in veterinary medicine. The purpose of this study was to report semiquantitative standard uptake values (SUV) of malignant and nonmalignant tissues and organs in canine cancer patients. FDG PET/CT was performed in 14 dogs including, nine mesenchymal tumors, four carcinomas, and one incompletely excised mast cell tumor. A generally higher FDG uptake was observed in carcinomas relative to sarcomas. Maximum SUV of carcinomas ranged from 7.6 to 27.0, and for sarcomas from 2.0 to 10.6. The FDG SUV of several organs and tissues, including regional brain uptake is reported, to serve as a reference for future FDG PET studies in canine cancer patients. Several potential pitfalls have been recognized in interpretation of FDG PET images of human patients, a number of these were also observed in this study.

Original language	English
Journal	Veterinary Radiology & Ultrasound
Volume	52
Issue number	2
Pages (from-to)	201-206
Number of pages	6
ISSN	1058-8183
DOIs	https://doi.org/10.1111/j.1740-8261.2010.01757.x
Publication status	Published - Mar 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/j.1740-8261.2010.01757.x

Cite this

@article{11fa8054a40547eb829841349206d29a,

title = "FDG PET/CT imaging in canine cancer patients",

abstract = "2-Deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography (FDG PET/CT) is becoming increasingly available as an imaging modality in veterinary medicine. The purpose of this study was to report semiquantitative standard uptake values (SUV) of malignant and nonmalignant tissues and organs in canine cancer patients. FDG PET/CT was performed in 14 dogs including, nine mesenchymal tumors, four carcinomas, and one incompletely excised mast cell tumor. A generally higher FDG uptake was observed in carcinomas relative to sarcomas. Maximum SUV of carcinomas ranged from 7.6 to 27.0, and for sarcomas from 2.0 to 10.6. The FDG SUV of several organs and tissues, including regional brain uptake is reported, to serve as a reference for future FDG PET studies in canine cancer patients. Several potential pitfalls have been recognized in interpretation of FDG PET images of human patients, a number of these were also observed in this study.",

author = "Hansen, {Anders Elias} and Fintan McEvoy and Engelholm, {Svend Aage} and Ian Law and Kristensen, {Annemarie Thuri}",

year = "2011",

month = mar,

doi = "10.1111/j.1740-8261.2010.01757.x",

language = "English",

volume = "52",

pages = "201--206",

journal = "Veterinary Radiology & Ultrasound",

issn = "1058-8183",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - FDG PET/CT imaging in canine cancer patients

AU - Hansen, Anders Elias

AU - McEvoy, Fintan

AU - Engelholm, Svend Aage

AU - Law, Ian

AU - Kristensen, Annemarie Thuri

PY - 2011/3

Y1 - 2011/3

N2 - 2-Deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography (FDG PET/CT) is becoming increasingly available as an imaging modality in veterinary medicine. The purpose of this study was to report semiquantitative standard uptake values (SUV) of malignant and nonmalignant tissues and organs in canine cancer patients. FDG PET/CT was performed in 14 dogs including, nine mesenchymal tumors, four carcinomas, and one incompletely excised mast cell tumor. A generally higher FDG uptake was observed in carcinomas relative to sarcomas. Maximum SUV of carcinomas ranged from 7.6 to 27.0, and for sarcomas from 2.0 to 10.6. The FDG SUV of several organs and tissues, including regional brain uptake is reported, to serve as a reference for future FDG PET studies in canine cancer patients. Several potential pitfalls have been recognized in interpretation of FDG PET images of human patients, a number of these were also observed in this study.

AB - 2-Deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography (FDG PET/CT) is becoming increasingly available as an imaging modality in veterinary medicine. The purpose of this study was to report semiquantitative standard uptake values (SUV) of malignant and nonmalignant tissues and organs in canine cancer patients. FDG PET/CT was performed in 14 dogs including, nine mesenchymal tumors, four carcinomas, and one incompletely excised mast cell tumor. A generally higher FDG uptake was observed in carcinomas relative to sarcomas. Maximum SUV of carcinomas ranged from 7.6 to 27.0, and for sarcomas from 2.0 to 10.6. The FDG SUV of several organs and tissues, including regional brain uptake is reported, to serve as a reference for future FDG PET studies in canine cancer patients. Several potential pitfalls have been recognized in interpretation of FDG PET images of human patients, a number of these were also observed in this study.

U2 - 10.1111/j.1740-8261.2010.01757.x

DO - 10.1111/j.1740-8261.2010.01757.x

M3 - Journal article

C2 - 21388475

SN - 1058-8183

VL - 52

SP - 201

EP - 206

JO - Veterinary Radiology & Ultrasound

JF - Veterinary Radiology & Ultrasound

IS - 2

ER -

FDG PET/CT imaging in canine cancer patients

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this